Clinical Trial Update: PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9

View source ↗

Summary

A clinical trial is evaluating PET imaging of systemic sclerosis using FDG and the radiotracer 68Ga-DOTA-Siglec-9, with enrollment by invitation at Turku Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• 68Ga-DOTA-Siglec-9
• FDG (fluorodeoxyglucose) (fluorodeoxyglucose)

Snippet

Sponsor: Turku University Hospital | Conditions: Systemic Sclerosis | Status: ENROLLING_BY_INVITATION